BioCryst Pharmaceuticals Profile

USD 0.05  1%
4.57Last Month High 5.21 
4.93Trading Day  High 5.08 

Sale by William Sheridan of 64310 shares of BioCryst Pharmaceuticals

BioCryst Pharmaceuticals Inc insider trading alert for sale of common stock by William Sheridan, Senior VP - CMO, on November 15, 2017. This event was filed by Biocryst Pharmaceuticals with SEC on 2017-11-15. Statement of changes in beneficial ownership - SEC Form 4. William Sheridan is currently serves as senior vice president chief medical officer of BioCryst Pharmaceuticals [view details]   

BioCryst Pharmaceuticals Summary

BioCryst Pharmaceuticals Inc (BCRX) is traded on NASDAQ in USA. It is located in NORTH CAROLINA, U.S.A and employs 70 people. BioCryst Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 480.22 M. BioCryst Pharmaceuticals Inc has 98.4 M outstanding shares of which 10.82 M shares are currently shorted by private and institutional investors with about 10.04 trading days to cover. BIOCRYST PHARM IN currently holds about 161.62 M in cash with (36.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.64.
Check BioCryst Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected BioCryst Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

BioCryst Pharmaceuticals Against Markets

Current Ratings  

BioCryst Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
< 51% 
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameBioCryst Pharmaceuticals Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business Address4505 Emperor Blvd., Suite 200, Durham, NC 27703, United States
CIK Number00882796.0
IndustryPharmaceutical Products
Contact Number919 859 1314
CurrencyUSD - US Dollar


BioCryst Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
BioCryst Pharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
BioCryst Pharmaceuticals Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


BioCryst Pharmaceuticals Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.25February 27, 2017
BioCryst Pharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate